Payer Almanac
About the data Sign in
Star measuresDisplay measuresHEDISWhy members leave

Measures · D14 in 2021 · Part D · DD4 Drug Safety and Accuracy of Drug Pricing

Statin Use in Persons with Diabetes (SUPD)

Drug PlanMedication AdherenceSource: Prescription Drug Events

What it measures
To lower their risk of developing heart disease, most people with diabetes should take cholesterol medication. This rating is based on the percent of plan members with diabetes who take the most effective cholesterol-lowering drugs. Plans can help make sure their members get these prescriptions filled.
How it's calculated
This measure is defined as the percent of Medicare Part D beneficiaries 40-75 years old who were dispensed at least two diabetes medication fills and received a statin medication fill during the measurement period. The percentage is calculated as the number of member-years of enrolled beneficiaries 40-75 years old who received a statin medication fill during the measurement period (numerator) divided by the number of member-years of enrolled beneficiaries 40-75 years old with at least two diabetes medication fills during the measurement period (denominator). The SUPD measure is adapted from the measure concept that was developed and endorsed by the Pharmacy Quality Alliance (PQA). See the medication list for this measure. The SUPD measure is calculated using the National Drug Code (NDC) lists updated by the PQA. The complete NDC lists, including diagnosis codes, are posted along with these technical notes.
Data source
Prescription Drug Event (PDE) data The data for this measure come from Prescription Drug Event (PDE) data submitted by drug plans to Medicare for dates of service from January 1, 2019-December 31, 2019, and processed by June 30, 2020. Only final action PDE claims are used to calculate the patient safety measures. PDE adjustments made post-reconciliation were not reflected in this measure. Additional data sources include the Common Medicare Environment (CME), the Medicare Enrollment Database (EDB), the Common Working File (CWF), and the Risk Adjustment Processing System (RAPS). • CME is used for enrollment information. • EDB is used for hospice enrollment and ESRD status (dialysis start and end dates within the measurement period). • CWF is used to identify exclusion diagnoses based on ICD-10-CM codes • RAPS is used for diagnosis information, RxHCC - Dialysis Status (most recent available Payment Year)
Measurement period
01/01/2019 – 12/31/2019
Better when
Higher
Weight
3 (Intermediate Outcome Measure)
Star assignment
Clustering
Case-mix adjusted
—
In improvement measure
Yes
Used in CAI
Yes
Exclusions
ShowContracts with 30 or fewer enrolled member-years (in the denominator). The following beneficiaries are excluded from the denominator if at any time during the measurement period: • Hospice enrollment • ESRD diagnosis or dialysis coverage dates
Notes
Part D drugs do not include drugs or classes of drugs, or their medical uses, which may be excluded from coverage or otherwise restricted under section 1927(d)(2) of the Act, except for smoking cessation agents. As such, these drugs, which may be included in the PQA medication or NDC lists, are excluded from CMS analyses. Also, the member- years of enrollment adjustment is made by CMS to account for partial enrollment within the benefit year. Enrollment is measured at the episode level, and inclusion in the measure is determined separately for each episode – i.e., to be included for a given episode, the beneficiary must meet the initial inclusion criteria for the measure during that episode. The measure is weighted based on the total number of member years for each episode in which the beneficiary meets the measure criteria. For instance, if a beneficiary is enrolled for a three-month episode, disenrolled for a six-month episode, reenrolled for a three-month episode, and meets the measure criteria during each enrollment episode, s/he will count as 0.5 member years in the rate calculation (3/12 + 3/12 = 6/12).
Disaster policy
Higher measure star (2020-2021) for contracts with 25% or more enrolled affected by 2019 disasters.

From the 2021 Star Ratings Technical Notes (CMS).

Cut points over time

Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.

How the 2028 cut points are projected

Each boundary moves by its median year-on-year change since 2019, capped at 5 points, the most CMS lets a non-survey cut point move in a year. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.

StarsOrg type2027Projected 2028Move
2★MA-PD8384.5+1.5
3★MA-PD8789+2
4★MA-PD9091+1
5★MA-PD9495+1
2★PDP8182.5+1.5
3★PDP8383.5+0.5
4★PDP8585.5+0.5
5★PDP8788+1

2021 star distribution

Not rated: Plan too new to be measured (186); Not enough data available (49); No data available (39); Plan not required to report measure (9)

Cut point bands

Star yearOrg type1★2★3★4★5★
2027MA-PD< 83 %>= 83 % to < 87 %>= 87 % to < 90 %>= 90 % to < 94 %>= 94 %
2027PDP< 81 %>= 81 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2026MA-PD< 81 %>= 81 % to < 85 %>= 85 % to < 89 %>= 89 % to < 93 %>= 93 %
2026PDP< 82 %>= 82 % to < 83 %>= 83 % to < 84 %>= 84 % to < 86 %>= 86 %
2025MA-PD< 81 %>= 81 % to < 86 %>= 86 % to < 89 %>= 89 % to < 93 %>= 93 %
2025PDP< 80 %>= 80 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2024MA-PD< 81 %>= 81 % to < 86 %>= 86 % to < 88 %>= 88 % to < 92 %>= 92 %
2024PDP< 81 %>= 81 % to < 83 %>= 83 % to < 85 %>= 85 % to < 87 %>= 87 %
2023MA-PD< 80 %>= 80 % to < 84 %>= 84 % to < 86 %>= 86 % to < 90 %>= 90 %
2023PDP< 80 %>= 80 % to < 82 %>= 82 % to < 84 %>= 84 % to < 86 %>= 86 %
2022MA-PD< 76 %>= 76 % to < 80 %>= 80 % to < 84 %>= 84 % to < 88 %>= 88 %
2022PDP< 77 %>= 77 % to < 79 %>= 79 % to < 82 %>= 82 % to < 84 %>= 84 %
2021MA-PD< 77 %>= 77 % to < 81 %>= 81 % to < 83 %>= 83 % to < 87 %>= 87 %
2021PDP< 74 %>= 74 % to < 79 %>= 79 % to < 82 %>= 82 % to < 85 %>= 85 %
2020MA-PD< 74%? 74% to < 78%? 78% to < 81%? 81% to < 83%? 83%
2020PDP< 76%? 76% to < 78%? 78% to < 79%? 79% to < 83%? 83%
2019MA-PD< 72%? 72% to < 76%? 76% to < 80%? 80% to < 83%? 83%
2019PDP< 73%? 73% to < 77%? 77% to < 79%? 79% to < 82%? 82%

Lowest-scoring contracts, 2021

ContractParentMembersScoreStarsΔShortfall to 4★Pctile
S1894 CommunityCare Prescription Drug Plan (PDP)St Francis Health System & St John Health System—681—140%
H5117 WellcareCentene Corporation0651—180%
H5377 HumanaHumana Inc.3,919661—170%
H3708 American Health Advantage of OklahomaMitchell Family Office5497010130%
H3206 Presbyterian Insurance Company, Inc.Presbyterian Healthcare Services—7010130%
H2591 Health Alliance MedicareThe Carle Foundation—711—121%
H6743 ATRIO Health PlansATRIO Health Plans21,0427110121%
H2392 Kansas Health AdvantageKansas Superior Select873721—111%
R7220 HumanaHumana Inc.2,904721−1111%
H4754 PacificSource MedicarePacificSource2,5277210111%
H7680 Prominence Health PlanUniversal Health Services, Inc.25,862731−1102%
H6502 Blue Medicare AdvantageBlue Cross and Blue Shield of Kansas City—7310102%
H3810 AllCare AdvantageAllCare Health, Inc.2,485731−1102%
S5916 Regence BlueShield of Idaho and Regence BC BS UtahCambia Health Solutions, Inc.1,098742082%
H5199 WellcareCentene Corporation—741—93%
H1099 Health First Health Plans, Inc.Health First Shared Services, Inc.37,197741093%
H4198 Integris Health Partners+ (HMO)St Francis Health System & St John Health System—741093%
H1304 Regence BlueShield of IdahoCambia Health Solutions, Inc.902741093%
H3814 ATRIO Health PlansATRIO Health Plans1,997741093%
H9811 WellcareCentene Corporation0741093%
R0802 Martin's Point Generations AdvantageMartin's Point Health Care, Inc.—741—93%
H1350 Blue Cross of IdahoGemstone Holdings, Inc.32,406741−193%
H2161 Upper Peninsula Health PlanDLP Marquette General Hospital, LLC—741−193%
H3251 Blue Cross and Blue Shield of New MexicoHealth Care Service Corporation19,880741−193%
H1664 WellcareCentene Corporation3,614741093%

History

Star yearCodeNameMeasuredWeightSource
2027D11Statin Use in Persons with Diabetes (SUPD)01/01/2025 – 12/31/20251Prescription Drug Events
2026D12Statin Use in Persons with Diabetes (SUPD)01/01/2024 – 12/31/20241Prescription Drug Events
2025D12Statin Use in Persons with Diabetes (SUPD)01/01/2023 – 12/31/20231Prescription Drug Events
2024D12Statin Use in Persons with Diabetes (SUPD)01/01/2022 – 12/31/20221Prescription Drug Events
2023D12Statin Use in Persons with Diabetes (SUPD)01/01/2021 – 12/31/20211Prescription Drug Events
2022D12Statin Use in Persons with Diabetes (SUPD)01/01/2020 – 12/31/20203Prescription Drug Events
2021D14Statin Use in Persons with Diabetes (SUPD)01/01/2019 – 12/31/20193Prescription Drug Events
2020D14Statin Use in Persons with Diabetes (SUPD)01/01/2018 – 12/31/20181Prescription Drug Events
2019D14Statin Use in Persons with Diabetes (SUPD)01/01/2017 – 12/31/20171Prescription Drug Events